需要订阅 JoVE 才能查看此. 登录或开始免费试用。
Method Article
介绍了一种制备聚 (五氟丙烯酸五氟苯基丙烯酸酯) (聚聚丙烯) 接枝二氧化硅微珠的制备方案。然后用抗体固定化聚多聚体 (pfpa) 功能化表面, 并通过免疫沉淀成功地用于蛋白质分离。
我们演示了一种制备聚 (五氟苯基丙烯酸酯) (聚 (pfpa) 接枝二氧化硅珠用于抗体固定化和随后免疫沉淀 (ip) 应用的简单方法。聚 (pfpa) 接枝表面是通过一个简单的两步工艺制备的。第一步, 3-氨基丙基三乙氧基硅烷 (aptes) 作为链接分子沉积在二氧化硅表面。在第二步中, 通过可逆添加和碎裂链转移 (raft) 聚合合成的聚 (ppa) 均聚物通过五氟苯基 (pfp) 单元在聚合物和 aptes 上的胺基团。通过 x 射线光电子能谱 (xps) 证实了 aptes 和聚 (ppa) 在二氧化硅颗粒上的沉积, 并通过动态光散射 (dls) 测量的粒径变化进行监测。为了提高珠子的表面亲水性, 还采用氨基化聚乙二醇 (氨基 peg) 部分取代了聚 (pfpa)。然后用抗体固定化聚乙二醇 (pfpa) 接枝二氧化硅微珠进行 ip 应用。为了进行演示, 采用了抗蛋白激酶 rna 激活 (pkr) 的抗体, ip 效率是由西方印迹决定的。分析结果表明, 抗体固定化珠确实可以用来丰富 pkr, 而非特异性蛋白质相互作用最小。
活性聚合物刷子近年来受到了广泛的关注。它们可用于固定在有机或无机材料上的功能分子, 以创建在检测和分离等领域的活化表面, 如检测和分离1、2、3、4、 5。在所报告的反应聚合物中, 含有五氟苯基酯单位的聚合物特别有用, 因为它们与胺的反应性很高, 对水解有抵抗力, 6。其中一种聚合物是聚 (pfpa), 它可以很容易地功能化后与分子含有一级或二级胺 7,8, 9,10。在一个例子中, 聚 (pfpa) 刷与氨基螺旋体反应, 以创建光反应表面7。
聚 (ppa) 的制备及其应用已在以前的一些出版物6、7、8、9、10、11、12中介绍 ,13,14,15,16,17。特别是, theato 和他们的同事报告了通过 "嫁接到" 和 "嫁接到" 方法7、8、10、11、12合成聚 (pfpa) 刷的情况。.在 "接枝到" 方法中, 合成了聚 (甲基硅基氧烷)-聚 (五氟苯基丙烯酸酯) (聚 (mssq-ppa)) 混合聚合物 8,10,11, 12.聚 (mssq) 组分能够与许多不同的有机和无机表面形成强烈的粘附, 从而使聚 (pfpa) 成分在涂层材料表面形成画笔层。在 "接枝自" 方法中, 采用表面启动可逆加法和碎裂链转移 (si-raft) 聚合制备聚 (pfpa) 刷7。在这种情况下, 表面固定链转移剂 (si-cta) 首先通过硅硅烷反应共价连接到基板上。固定化的 si-cta 随后参与了 pfpa 单体的 si-raft 聚合, 产生了与基材有稳定共价连接的密集填充聚 (pfpa) 刷子。
利用通过 si-raft 聚合合成的聚 (pfpa) 刷, 我们最近证明了聚接枝二氧化硅颗粒上抗体的固定化及其随后在蛋白质纯化中的应用 18.使用聚 (pfpa) 刷进行抗体固定被发现可以解决一些与当前通过 ip 分离蛋白质相关的问题。传统的 ip 依靠使用蛋白阿比作为抗体固定的链接器 19,20,21。由于使用蛋白 a 可以使抗体具有特定的方向, 因此实现了高目标抗原的恢复效率。然而, 蛋白 a 的使用存在着非特异性蛋白质相互作用以及蛋白质恢复过程中抗体的丢失, 这两者都导致了高水平的背景噪声。为了解决这些缺点, 已经探索了抗体与固体支持的直接交联。由于交联抗体的随机方向, 这类技术的效率通常很低。对于聚 (pfpa) 接枝底物, 抗体的固定化是永久性的, 是通过 pfp 装置和胺功能对抗体的交换反应来实现的。虽然抗体取向仍然是随机的, 但该系统受益于有许多反应性的 pfp 位点, 可通过聚合程度来控制。此外, 我们还表明, 通过用氨基 peg 部分取代 pfp 单元, 可以调整表面亲水性, 进一步提高系统18的蛋白质回收效率.总体而言, 聚 (pfpa) 接枝二氧化硅颗粒被证明是传统 ip 的有效替代品, 具有合理的效率和更清洁的背景。
在这篇贡献中, 我们报告了一种替代方法, 用于制备用于抗体固定和 ip 应用的聚 (pfpa) 接枝表面。在一个简单的两步过程中, 如图 1所示, aptes 链接器分子首先沉积在二氧化硅表面, 然后聚 (ppa) 聚合物通过 pfp 单元之间的反应共价地附着在链接器分子上。聚合物和胺功能在 aptes 上。这种制备方法允许聚 (pfpa) 与基材表面永久交联, 但避免了与超金属-cta 合成和聚刷子 si-raft 聚合相关的许多并发症。仍然可以部分用氨基 peg 取代私营部门筹资和伙伴关系方案装置, 从而能够对聚合物刷子表面特性进行微调。我们表明, 这样制备的聚 (pfpa) 接枝二氧化硅珠可以用抗体固定化, 并用于通过 ip 浓缩蛋白质。本文详细介绍了珠子制备过程、抗体固定和 ip 检测, 供有兴趣寻求替代传统的基于蛋白质 a 的 ip 的读者使用。
Access restricted. Please log in or start a trial to view this content.
1. 制备聚 (ppa) 共聚物
2. 制备聚 (ppa) 功能化 sio2 珠
3. 用 pfpa 接枝的 sio2珠的制备
4. 聚极 (pfpa) 接枝 sio2珠的抗体固定
注: 无论聚 (pfpa) 上的 peg 取代百分比是什么, 都使用相同的程序。通过在 tdw 中溶解 pbs 片制备磷酸盐缓冲盐水 (pbs)。在 pbs 中加入半1000丁-20 (pbst), 制备0.1% 的磷酸盐缓冲盐水。
5. 细胞裂解和免疫沉淀
Access restricted. Please log in or start a trial to view this content.
图 1显示了制备聚 (pfpa) 接枝 sio2珠的原理图, 无论是否有 peg 取代。为了监测 aptes 和聚 (ppa) 接枝过程, 裸露的 sio2珠子、aptes 功能化的 sio2珠子和聚 (pfpa) 接枝的 sio2 珠子都以 dls (图 2) 和 xps (图 3) 为特征。珠子的 ip 效率是由西方印迹决定的。图 4显示?...
Access restricted. Please log in or start a trial to view this content.
聚 (pfpa) 接枝 sio2 珠的合成如图 1所示。通过使用 aptes 作为链接分子, 聚 (pfpa) 刷共价接枝到 sio2 基板可以通过一个简单的两步过程制备。虽然一些私营部门筹资和伙伴关系司单位被牺牲用于与 aptes 的反应, 但预计大量私营部门筹资和伙伴关系方案单位将继续可用, 以便以后与氨基-peg 或抗体发生反应。众所周知, pfp 基团形成低能量表面, 因此聚 (ppa) 刷子不能?...
Access restricted. Please log in or start a trial to view this content.
作者没有什么可透露的。
这项工作得到了国防发展机构的支持 (第1号批准。ud170039 id)。
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
2,2-Azobisisobutyronitrile, 99% | Daejung Chemicals | 1102-4405 | |
Methyl alcohol for HPLC, 99.9% | Duksan Pure Chemicals | d62 | |
Phenylmagnesium bromide solution 1.0 M in THF | Sigma-Aldrich | 331376 | |
Carbon disulfide anhydrous, ≥99% | Sigma-Aldrich | 335266 | |
Benzyl bromide, 98% | Sigma-Aldrich | B17905 | |
Petroleum ether, 90% | Samchun Chemicals | P0220 | |
Ethyl ether, 99% | Daejung Chemicals | 4025-4404 | |
Magnesium sulfate anhydrous, powder, 99% | Daejung Chemicals | 5514-4405 | |
Pentafluorophenyl acrylate | Santa Cruz Biotechnology | sc-264001 | contains inhibitor |
Aluminium oxide, activated, basic, Brockmann I | Sigma-Aldrich | 199443 | |
Sodium Chloride (NaCl) | Daejung Chemicals | 7548-4400 | |
Anisole anhydrous, 99.7% | Sigma-Aldrich | 296295 | |
Silica nanoparticle | Microparticles GmbH | SiO2-R-0.7 | 5% w/v aqueous suspension |
3-Aminopropyltrimethoxysilane, >96.0% | Tokyo Chemical Industry | T1255 | |
Dimethyl sulfoxide for HPLC, ≥99.7% | Sigma-Aldrich | 34869 | |
Amino-terminated poly(ethylene glycol) methyl ether | Polymer Source | P16082-EGOCH3NH2 | |
Phosphate buffered saline tablet | Takara | T9181 | |
Tween-20 | Calbiochem | 9480 | |
Tris-HCl (pH 8.0) | Invitrogen | AM9855G | |
KCl | Invitrogen | AM9640G | |
NP-40 | VWR | E109-50ML | |
Glycerol | Invitrogen | 15514-011 | |
Dithiothreitol | Biosesang | D1037 | |
Protease inhibitor | Merck | 535140-1MLCN | |
Bromo phenol blue | Sigma-Aldrich | B5525-5G | |
Tris-HCl (pH 6.8) | Biosolution | BT033 | |
Sodium dodecyl sulfate | Biosolution | BS003 | |
2-Mercaptoethanol | Gibco | 21985-023 | |
PKR Antibody | Cell Signaling Technology | 12297S | |
GAPDH Antibody | Santa Cruz Biotechnology | sc-32233 | |
Normal Rabbit IgG | Cell Signaling Technology | 2729S | |
HeLa | Korea Cell Line Bank | 10002 | |
Sonicator | DAIHAN Scientific | WUC-D10H | |
Ultrasonicator | BMBio | BR2006A | |
Centrifuge I | Eppendorf | 5424 R | |
Centrifuge II | LABOGENE | 1736R | |
Rotator | FINEPCR | ROTATOR/AG | |
Vacuum oven | DAIHAN Scientific | ThermoStable OV-30 | |
Gel permeation chromatography (THF) | Agilent Technologies | 1260 Infinity II | |
X-ray photoelectron spectrometer | Thermo VG Scientific | Sigma Probe | |
Dynamic light scattering | Malvern Instruments | ZEN 3690 |
Access restricted. Please log in or start a trial to view this content.
An erratum was issued for: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification. Throughout the article, the term "3-aminopropyltriethoxysilane" has been replaced with "3-aminopropyltrimethoxysilane", and "APTES" with "APTMS".
The Keywords were updated from:
Poly(pentafluorophenyl acrylate), 3-aminopropyltriethoxysilane, reactive polymer brush, post-polymerization functionalization, antibody immobilization, immunoprecipitation
to:
Poly(pentafluorophenyl acrylate), 3-aminopropyltrimethoxysilane, reactive polymer brush, post-polymerization functionalization, antibody immobilization, immunoprecipitation
The Abstract was updated from:
We demonstrate a simple method to prepare poly(pentafluorophenyl acrylate) (poly(PFPA)) grafted silica beads for antibody immobilization and subsequent immunoprecipitation (IP) application. The poly(PFPA) grafted surface is prepared via a simple two-step process. In the first step, 3-aminopropyltriethoxysilane (APTES) is deposited as a linker molecule onto the silica surface. In the second step, poly(PFPA) homopolymer, synthesized via the reversible addition and fragmentation chain transfer (RAFT) polymerization, is grafted to the linker molecule through the exchange reaction between the pentafluorophenyl (PFP) units on the polymer and the amine groups on APTES. The deposition of APTES and poly(PFPA) on the silica particles are confirmed by X-ray photoelectron spectroscopy (XPS), as well as monitored by the particle size change measured via dynamic light scattering (DLS). To improve the surface hydrophilicity of the beads, partial substitution of poly(PFPA) with amine-functionalized poly(ethylene glycol) (amino-PEG) is also performed. The PEG-substituted poly(PFPA) grafted silica beads are then immobilized with antibodies for IP application. For demonstration, an antibody against protein kinase RNA-activated (PKR) is employed, and IP efficiency is determined by Western blotting. The analysis results show that the antibody immobilized beads can indeed be used to enrich PKR while non-specific protein interactions are minimal.
to:
We demonstrate a simple method to prepare poly(pentafluorophenyl acrylate) (poly(PFPA)) grafted silica beads for antibody immobilization and subsequent immunoprecipitation (IP) application. The poly(PFPA) grafted surface is prepared via a simple two-step process. In the first step, 3-aminopropyltrimethoxysilane (APTMS) is deposited as a linker molecule onto the silica surface. In the second step, poly(PFPA) homopolymer, synthesized via the reversible addition and fragmentation chain transfer (RAFT) polymerization, is grafted to the linker molecule through the exchange reaction between the pentafluorophenyl (PFP) units on the polymer and the amine groups on APTMS. The deposition of APTMS and poly(PFPA) on the silica particles are confirmed by X-ray photoelectron spectroscopy (XPS), as well as monitored by the particle size change measured via dynamic light scattering (DLS). To improve the surface hydrophilicity of the beads, partial substitution of poly(PFPA) with amine-functionalized poly(ethylene glycol) (amino-PEG) is also performed. The PEG-substituted poly(PFPA) grafted silica beads are then immobilized with antibodies for IP application. For demonstration, an antibody against protein kinase RNA-activated (PKR) is employed, and IP efficiency is determined by Western blotting. The analysis results show that the antibody immobilized beads can indeed be used to enrich PKR while non-specific protein interactions are minimal.
The fourth paragraph of the Introduction was updated from:
In this contribution, we report an alternative method to prepare poly(PFPA) grafted surface for antibody immobilization and IP application. In a simple two-step process, as illustrated in Figure 1, an APTES linker molecule is first deposited onto the silica surface, then the poly(PFPA) polymer is covalently attached to the linker molecule through the reaction between the PFP units on the polymer and the amine functions on APTES. This preparation method allows for the permanent crosslinking of poly(PFPA) to a substrate surface, but avoids the many complications associated with SI-CTA synthesis and SI-RAFT polymerization of poly(PFPA) brushes. Partial substitution of the PFP units with amino-PEG can still be performed, allowing fine-tuning of the polymer brush surface properties. We show the poly(PFPA) grafted silica beads thus prepared can be immobilized with antibodies and used for protein enrichment via IP. The detailed bead preparation procedure, antibody immobilization, and IP testing are documented in this article, for readers interested in seeking an alternative to conventional Protein A/G based IP.
to:
In this contribution, we report an alternative method to prepare poly(PFPA) grafted surface for antibody immobilization and IP application. In a simple two-step process, as illustrated in Figure 1, an APTMS linker molecule is first deposited onto the silica surface, then the poly(PFPA) polymer is covalently attached to the linker molecule through the reaction between the PFP units on the polymer and the amine functions on APTMS. This preparation method allows for the permanent crosslinking of poly(PFPA) to a substrate surface, but avoids the many complications associated with SI-CTA synthesis and SI-RAFT polymerization of poly(PFPA) brushes. Partial substitution of the PFP units with amino-PEG can still be performed, allowing fine-tuning of the polymer brush surface properties. We show the poly(PFPA) grafted silica beads thus prepared can be immobilized with antibodies and used for protein enrichment via IP. The detailed bead preparation procedure, antibody immobilization, and IP testing are documented in this article, for readers interested in seeking an alternative to conventional Protein A/G based IP.
Step 2.1 of the Protocol was updated from:
Treatment of SiO2 beads with APTES
to:
Treatment of SiO2 beads with APTMS
Step 2.1.1 of the Protocol was updated from:
SiO2 particles are available in the form of a 5% (w/v) aqueous suspension. Combine 0.8 mL of SiO2 suspension with 40 mg of APTES and 8 mL of methanol in a 20 mL scintillation vial equipped with a stir bar.
to:
SiO2 particles are available in the form of a 5% (w/v) aqueous suspension. Combine 0.8 mL of SiO2 suspension with 40 mg of APTMS and 8 mL of methanol in a 20 mL scintillation vial equipped with a stir bar.
Step 2.1.3 of the Protocol was updated from:
Transfer the solution to a conical tube. To isolate the APTES functionalized SiO2 beads, centrifuge the solution at 10,000 x g for 5 min, then remove the supernatant. Wash the beads by re-dispersing them in 3 mL of fresh methanol. Shake the tube by hand for mixing, but if necessary, improve the dispersion by sonication in a water bath for a few seconds. Centrifuge the beads at 10,000 x g for 5 min. Remove the supernatant and repeat the wash step one more time.
to:
Transfer the solution to a conical tube. To isolate the APTMS functionalized SiO2 beads, centrifuge the solution at 10,000 x g for 5 min, then remove the supernatant. Wash the beads by re-dispersing them in 3 mL of fresh methanol. Shake the tube by hand for mixing, but if necessary, improve the dispersion by sonication in a water bath for a few seconds. Centrifuge the beads at 10,000 x g for 5 min. Remove the supernatant and repeat the wash step one more time.
Step 2.1.4 of the Protocol was updated from:
Combine the methanol washed SiO2 beads with 3 mL of dimethyl sulfoxide (DMSO). Shake the mixture by hand, or if necessary sonicate for a few seconds, until the beads are fully dispersed in DMSO. Centrifuge the beads at 10,000 x g for 5 min, then remove the supernatant. Repeat the step to ensure complete solvent exchange from methanol to DMSO.to:
Combine the methanol washed SiO2 beads with 3 mL of dimethyl sulfoxide (DMSO). Shake the mixture by hand, or if necessary sonicate for a few seconds, until the beads are fully dispersed in DMSO. Centrifuge the beads at 10,000 x g for 5 min, then remove the supernatant. Repeat the step to ensure complete solvent exchange from methanol to DMSO.
NOTE: The final suspension contains the APTMS functionalized SiO2 beads dispersed in 4 mL of DMSO.
Step 2.2 of the Protocol was updated from:
Grafting poly(PFPA) to APTES functionalized SiO2 beads
to:
Grafting poly(PFPA) to APTMS functionalized SiO2 beads
Step 2.2.2 of the Protocol was updated from:
Add 1 mL of APTES functionalized SiO2 beads suspended in DMSO (from Step 2.1.4) to the poly(PFPA) solution. React at RT for 1 h with vigorous stirring.
to:
Add 1 mL of APTMS functionalized SiO2 beads suspended in DMSO (from Step 2.1.4) to the poly(PFPA) solution. React at RT for 1 h with vigorous stirring.
Step 3.4 of the Protocol was updated from:
To prepare APTES functionalized SiO2 beads suspended in DMSO, follow the same steps shown in Step 2.1. Transfer 1 mL of the bead suspension into the PEG-substituted poly(PFPA) solution prepared in Step 3.3. Allow the grafting between poly(PFPA) and APTES functionalized SiO2 beads to proceed at RT for 1 h with vigorous stirring.
to:
To prepare APTMS functionalized SiO2 beads suspended in DMSO, follow the same steps shown in Step 2.1. Transfer 1 mL of the bead suspension into the PEG-substituted poly(PFPA) solution prepared in Step 3.3. Allow the grafting between poly(PFPA) and APTMS functionalized SiO2 beads to proceed at RT for 1 h with vigorous stirring.
The first paragraph of the Representative Results was updated from:
A schematic for the preparation of poly(PFPA) grafted SiO2 beads, with or without PEG substitution is shown in Figure 1. To monitor the APTES and poly(PFPA) grafting process, bare SiO2 beads, APTES functionalized SiO2 beads, and poly(PFPA) grafted SiO2 beads are characterized by both DLS (Figure 2) and XPS (Figure 3). IP efficiencies of the beads are determined by Western blotting. Figure 4 shows the Western blotting results for IP using 1% PEG-substituted poly(PFPA) grafted beads, where the beads are incubated with no antibody, a non-specific antibody, or anti-PKR antibody. Figure 5 shows the Western blotting results for IP using 0% PEG-substituted poly(PFPA) grafted beads and 1% PEG-substituted poly(PFPA) grafted beads, both incubated with anti-PKR antibodies.
to:
A schematic for the preparation of poly(PFPA) grafted SiO2 beads, with or without PEG substitution is shown in Figure 1. To monitor the APTMS and poly(PFPA) grafting process, bare SiO2 beads, APTMS functionalized SiO2 beads, and poly(PFPA) grafted SiO2 beads are characterized by both DLS (Figure 2) and XPS (Figure 3). IP efficiencies of the beads are determined by Western blotting. Figure 4 shows the Western blotting results for IP using 1% PEG-substituted poly(PFPA) grafted beads, where the beads are incubated with no antibody, a non-specific antibody, or anti-PKR antibody. Figure 5 shows the Western blotting results for IP using 0% PEG-substituted poly(PFPA) grafted beads and 1% PEG-substituted poly(PFPA) grafted beads, both incubated with anti-PKR antibodies.
Figure 1 was updated from:
Figure 1: Schematic for the preparation of poly(PFPA) grafted SiO2 beads using APTES as a linker molecule. (a) Poly(PFPA) grafted beads. (b) Partially PEG-substituted poly(PFPA) grafted beads.
to:
Figure 1: Schematic for the preparation of poly(PFPA) grafted SiO2 beads using APTMS as a linker molecule. (a) Poly(PFPA) grafted beads. (b) Partially PEG-substituted poly(PFPA) grafted beads.
Figure 2 was updated from:
Figure 2: DLS measurements for (a) bare SiO2 beads (SiO2), (b) APTES functionalized SiO2 beads (APTES-SiO2), and (c) poly(PFPA) grafted SiO2 beads (poly(PFPA)-SiO2), dispersed in DMSO. The Z-average diameter (d) and polydispersity index (PDI) of each sample are reported.
to:
Figure 2: DLS measurements for (a) bare SiO2 beads (SiO2), (b) APTMS functionalized SiO2 beads (APTMS-SiO2), and (c) poly(PFPA) grafted SiO2 beads (poly(PFPA)-SiO2), dispersed in DMSO. The Z-average diameter (d) and polydispersity index (PDI) of each sample are reported.
Figure 3 was updated from:
Figure 3: XPS spectra for bare SiO2 beads (SiO2), APTES functionalized SiO2 beads (APTES-SiO2), and poly(PFPA) grafted SiO2 beads (poly(PFPA)-SiO2). The peaks examined correspond to (a) Si 2p, (b) O 1s, (c) N 1s, and (d) F 1s.
to:
Figure 3: XPS spectra for bare SiO2 beads (SiO2), APTMS functionalized SiO2 beads (APTMS-SiO2), and poly(PFPA) grafted SiO2 beads (poly(PFPA)-SiO2). The peaks examined correspond to (a) Si 2p, (b) O 1s, (c) N 1s, and (d) F 1s.
The first and second paragraphs of the Discussion were updated from:
The synthesis of poly(PFPA) grafted SiO2 beads is illustrated in Figure 1. By employing APTES as a linker molecule, poly(PFPA) brushes covalently grafted to SiO2 substrate can be prepared via a simple two-step process. Although some of the PFP units are sacrificed for the reaction with APTES, a large number of the PFP units are expected to remain available for later reaction with either amino-PEG or antibodies. The PFP groups are known to form low energy surfaces so poly(PFPA) brushes do not solvate well in water28. For IP application, the antibodies need to be immobilized on the poly(PFPA) brushes, and this exchange reaction is done in aqueous buffer solution in order to preserve the activity of the antibodies. As reported in our previous publication, partial substitution of the PFP units with hydrophilic molecules such as amine-functionalized PEG can improve surface hydrophilicity, leading to increased antibody immobilization efficiency18. In this study, partially PEG substituted poly(PFPA) is also prepared, then grafted to the SiO2 surface using the same APTES linker molecule. Overall, the methods illustrated in Figure 1 allow the preparation of poly(PFPA) grafted surfaces with different degrees of PEG substitution. These polymer brushes with tunable surface properties provide an ideal platform for antibody immobilization and subsequent IP application.
The bead preparation process is monitored by both DLS and XPS. The DLS results for various functionalized SiO2 beads in DMSO are summarized in Figure 2. The bare SiO2 beads exhibit hydrodynamic diameter of 666 nm, in agreement with the manufacturer reported bead size (0.676 μm; SD = 0.03 μm). After APTES treatment, the bead diameter increases to 740 nm; and with poly(PFPA) treatment, the bead diameter further increases to 1889 nm. It is important to point out that the polydispersity index (PDI) for the poly(PFPA) grafted beads is rather large (PDI = 0.76), which is indicative of poor quality sample containing large aggregates. Although the DLS curve only shows one nano-sized peak, small amount of aggregates may be present in the suspension. The functionalized SiO2 beads are also examined by XPS to determine surface composition (Figure 3). Following APTES treatment, N 1s peak associated with the amine groups on APTES is detected. And, following poly(PFPA) treatment, F 1s peak associated with the PFP units on the polymer is detected. Together these data show the successful functionalization of the SiO2 surface, first with APTES, then with poly(PFPA).
to:
The synthesis of poly(PFPA) grafted SiO2 beads is illustrated in Figure 1. By employing APTMS as a linker molecule, poly(PFPA) brushes covalently grafted to SiO2 substrate can be prepared via a simple two-step process. Although some of the PFP units are sacrificed for the reaction with APTMS, a large number of the PFP units are expected to remain available for later reaction with either amino-PEG or antibodies. The PFP groups are known to form low energy surfaces so poly(PFPA) brushes do not solvate well in water28. For IP application, the antibodies need to be immobilized on the poly(PFPA) brushes, and this exchange reaction is done in aqueous buffer solution in order to preserve the activity of the antibodies. As reported in our previous publication, partial substitution of the PFP units with hydrophilic molecules such as amine-functionalized PEG can improve surface hydrophilicity, leading to increased antibody immobilization efficiency18. In this study, partially PEG substituted poly(PFPA) is also prepared, then grafted to the SiO2 surface using the same APTMS linker molecule. Overall, the methods illustrated in Figure 1 allow the preparation of poly(PFPA) grafted surfaces with different degrees of PEG substitution. These polymer brushes with tunable surface properties provide an ideal platform for antibody immobilization and subsequent IP application.
The bead preparation process is monitored by both DLS and XPS. The DLS results for various functionalized SiO2 beads in DMSO are summarized in Figure 2. The bare SiO2 beads exhibit hydrodynamic diameter of 666 nm, in agreement with the manufacturer reported bead size (0.676 μm; SD = 0.03 μm). After APTMS treatment, the bead diameter increases to 740 nm; and with poly(PFPA) treatment, the bead diameter further increases to 1889 nm. It is important to point out that the polydispersity index (PDI) for the poly(PFPA) grafted beads is rather large (PDI = 0.76), which is indicative of poor quality sample containing large aggregates. Although the DLS curve only shows one nano-sized peak, small amount of aggregates may be present in the suspension. The functionalized SiO2 beads are also examined by XPS to determine surface composition (Figure 3). Following APTMS treatment, N 1s peak associated with the amine groups on APTMS is detected. And, following poly(PFPA) treatment, F 1s peak associated with the PFP units on the polymer is detected. Together these data show the successful functionalization of the SiO2 surface, first with APTMS, then with poly(PFPA).
请求许可使用此 JoVE 文章的文本或图形
请求许可This article has been published
Video Coming Soon
版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。